MRNA Today - Jul 09: Morgan Stanley Neutral Rating

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

MRNA Today - Jul 09: Morgan Stanley Neutral Rating

無料で聴く

ポッドキャストの詳細を見る

Hey there! I’m Joey, your go-to guy for stock talk. I’ve been investing for years, and today, we’re chatting about Moderna, ticker MRNA. It was a bit of a mixed bag today, closing up about 3.5%.

So, what happened? Well, it started strong but then kind of fizzled out. Moderna hit a high earlier this week but then took a hit after some news came through. People were feeling optimistic—like, it had a nice little run recently. But then Morgan Stanley decided to stick with a neutral rating on the stock. Yeah, that one stung a bit, especially since they did raise their price target but didn’t give it a glowing review.

Now, why did investors seem to hit the sell button? It looks like there’s a bit of a disconnect between the price target bump and the neutral stance. Some folks were hoping for a more bullish take, especially after that recent surge of 37% over six days. It seems like the market was kinda like, "Well, if they’re not super excited, why should we be?" That led to some selling pressure, and the stock dipped from its recent highs.

On the flip side, there’s still some good stuff happening. Moderna’s got a corporate update scheduled for July 31. They’re planning to share some results, and who knows? That could shake things up again.

So, to wrap it all up, Moderna had a decent day, but the Morgan Stanley news definitely brought it down from those highs. Always a bit of a rollercoaster, right? Just remember, I’m here to keep you in the loop for fun and info, not to give any financial advice. Catch you later!

まだレビューはありません